B9D2: A Protein Implicated in A Number of Diseases (G80776)

Target Name: B9D2

NCBI ID: G80776

B9D2

B9D2: A Protein Implicated in A Number of Diseases

B9D2, also known as B9-120, is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of cell adhesion and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of B9D2 is its role in cell adhesion. B9D2 is a transcription factor that has been shown to play a role in the regulation of cell adhesion, meaning that it helps to keep cells together in order to maintain tissue structure and function. This is important for many different cell types, including neurons and muscle cells, as it helps to ensure that they stick together and form distinct tissues.

In addition to its role in cell adhesion, B9D2 has also been shown to play a number of other important functions. For example, it has been shown to be involved in the regulation of the blood-brain barrier, which is a barrier that helps to protect the brain from harmful substances that could enter it. This is important for maintaining the health and function of the brain, as it helps to prevent things like viruses, bacteria, and other toxins from entering the brain and causing illness.

Another important function of B9D2 is its role in the regulation of inflammation. B9D2 has been shown to play a key role in the regulation of inflammatory responses, meaning that it helps to control the amount of inflammation that occurs in the body. This is important for maintaining the health and function of tissues, as too much inflammation can cause damage and contribute to a number of diseases.

In addition to its roles in cell adhesion, inflammation, and other functions, B9D2 has also been shown to be involved in a number of diseases and disorders. For example, B9D2 has been shown to be involved in the development and progression of cancer, as well as in the regulation of the immune response. It has also been shown to be involved in a number of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, as well as in autoimmune disorders like rheumatoid arthritis and multiple sclerosis.

Given its involvement in a number of important functions and its association with a number of diseases, B9D2 is an attractive target for research and development. There is ongoing research into the potential uses of B9D2 as a drug or biomarker, with a focus on its potential as a treatment for a number of different conditions, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key advantages of B9D2 as a potential drug or biomarker is its relatively simple structure. B9D2 is a small protein that is expressed in a variety of tissues throughout the body, which makes it relatively easy to study and develop treatments. Additionally, because B9D2 is a transcription factor, it is relatively stable and can be used in a variety of formats, such as cell-based assays or ELISA assays, which makes it easier to study and compare different treatments.

Another advantage of B9D2 is its potential to be used in combination with other treatments. Because B9D2 is involved in a number of different functions and has been shown to play a role in the regulation of both cell adhesion and inflammation, it has the potential to be used in a variety of different treatments. For example, it could be used in combination with chemotherapy or radiation therapy to help stimulate an immune response against cancer cells. Additionally, it could be used in combination with other drugs or therapies to help regulate the immune response and prevent the development of autoimmune disorders.

Overall, B9D2 is an interesting protein that has the potential to be a drug or biomarker. Its relatively simple structure, its involvement in a number of different functions, and its potential to be used in combination with other treatments make it an attractive target for research and development. As

Protein Name: B9 Domain Containing 2

Functions: Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes

The "B9D2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about B9D2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets